2025-04-26 - Analysis Report
## Natera Inc. (NTRA) Stock Analysis

**0. Key Figures:**

* **Cumulative Return (NTRA):** 133.46%
* **Cumulative Return (VOO):** 78.33%
* **Return Difference:** 55.1%
* **Relative Divergence:** 15.4% (Indicates NTRA's performance is in the upper 15.4% of its historical range relative to VOO.)


**1. Company Overview and Performance Comparison:**

Natera Inc. is a company focused on providing genetic testing and other related services.  Over the period analyzed, NTRA significantly outperformed the S&P 500 (VOO), with a cumulative return of 133.46% compared to VOO's 78.33%. The 55.1% difference highlights NTRA's superior performance.  However, the relative divergence suggests that this outperformance is not unprecedented within the historical context of the company's performance relative to the S&P 500.

**Alpha and Beta Analysis:**

The provided data shows volatile alpha and beta values, indicating inconsistent performance relative to the market. High alpha values (e.g., 1.3 in 2017-2019 and 2021-2023) suggest significant outperformance, while negative CAGR and significant maximum drawdowns (MDD) in certain periods (e.g., -482% CAGR in 2021-2023) highlight significant risk. Market capitalization (Cap) has increased over time, indicating growth.

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|-------|-------|
| 2015-2017  | -6.0% | 62.4% | -0.1  | 1.2   |       |
| 2016-2018  | 29.0% | 80.1% | 0.0   | 1.9   |       |
| 2017-2019  | 159.0%| 80.1% | 1.3   | 4.6   |       |
| 2018-2020  | 530.0%| 80.1% | 0.7   | 13.5  |       |
| 2019-2021  | 355.0%| 62.9% | 0.3   | 12.7  |       |
| 2020-2022  | -119.0%| 62.9% | 0.3   | 5.5   |       |
| 2021-2023  | -482.0%| 69.9% | 1.3   | 8.5   |       |
| 2022-2024  | -75.0% | 70.6% | 1.3   | 21.5  |       |
| 2023-2025  | 82.0% | 72.8% | 0.9   | 20.9  |       |


**2. Recent Price Movement:**

* **Closing Price:** $153.79
* **5-Day Moving Average:** $148.74
* **20-Day Moving Average:** $144.88
* **60-Day Moving Average:** $153.69

The price is slightly above the 60-day moving average, suggesting a relatively stable price in the recent past, but below the previous close, indicating a slight downward trend.  The price is significantly above the 5-day and 20-day moving averages.

**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.39 (Medium Risk)
* **RSI:** 64.28 (Slightly above neutral; not overbought)
* **PPO:** 0.94 (Positive; bullish signal)
* **Recent Relative Divergence Change:** +0.1 (Short-term upward trend)
* **Expected Return:** 102.3% (Significant potential outperformance of VOO over the long term, but high risk implied in the high expected return)

The recent price drop (-$0.45) is relatively minor and doesn't indicate a significant bearish event.  The combination of indicators suggests a cautiously optimistic outlook, though the high expected return should be viewed with caution given the historical volatility shown in the alpha/beta analysis.

**4. Recent Earnings Analysis:**

The company has reported consistent revenue growth, but significant net losses (negative EPS) throughout the analyzed period.  It is important to note that the 2024-11-12 data appears duplicated.

| Date        | EPS     | Revenue       |
|-------------|---------|---------------|
| 2024-11-12  | -$0.26  | $0.44B        |
| 2024-08-09  | -$0.30  | $0.41B        |
| 2024-05-10  | -$0.56  | $0.37B        |
| 2023-11-09  | -$0.95  | $0.27B        |
| 2024-11-12  | -$0.95  | $0.27B        |


**5. Financial Information:**

Revenue has been steadily increasing, indicating growth. Profit margins are high and also increasing, but the company is currently operating at a loss.  ROE is negative, suggesting the company is not efficiently using its equity to generate profits.  The negative ROE needs further investigation and it is not clear if there are unusual items distorting it.

| Quarter     | Revenue | Profit Margin | Equity | ROE      |
|-------------|----------|---------------|---------|----------|
| 2024-12-31  | $0.48B  | 62.94%        | $1.20B | -4.50%   |
| 2024-09-30  | $0.44B  | 61.79%        | $0.88B | -3.60%   |
| 2024-06-30  | $0.41B  | 58.83%        | $0.84B | -4.48%   |
| 2024-03-31  | $0.37B  | 56.72%        | $0.79B | -8.51%   |
| 2023-12-31  | $0.31B  | 51.38%        | $0.77B | -10.20%  |


**6. Overall Analysis:**

NTRA has shown significant potential for growth and outperformance compared to the S&P 500, as evidenced by its high cumulative return and, at times, strong alpha. However, this comes with substantial risk, as indicated by the highly volatile performance, negative ROE, negative EPS and significant drawdowns.  The high expected return is alluring, but should be considered with caution given the substantial risk profile and inconsistencies in performance.  Further due diligence, including a thorough review of the company's financials and future prospects, is crucial before making any investment decision.  The negative ROE requires further investigation to determine the underlying cause.  Investors should be comfortable with high volatility and a potentially long timeline before realizing any returns.
